Experience boss Kardes sold $448,140 worth of shares from Investing.com

Hakan Kardes, the chief experience officer at Alignment Healthcare, Inc. (NASDAQ:ALHC), a healthcare company with a market capitalization of $2.4 billion, recently sold 35,000 shares of company stock. According to InvestingPro data, ALHC has delivered an impressive return of over 80% over the past six months. The shares were sold at a weighted average price of $12,804 per share, for a total transaction value of $448,140.

The sales occurred on November 27, 2024, with the stock price fluctuating between $12.62 and $12.89 per share. After this transaction, Kardes still holds 320,444 shares. Although the company is currently trading close to its fair value as determined by InvestingPro, investors should note that analysts continue to expect losses this year. For more detailed insights and eight other important ProTips, check out the comprehensive Pro Research Report, available exclusively on InvestingPro.

Focus Healthcare Recently been in the focus of positive financial developments. Financial services firm TD Cowen raised its price target on Alignment Healthcare to $13 and maintained a Buy rating on the stock. Key to this decision were the company’s strong third-quarter 2024 results, which exceeded consensus estimates for revenue, gross profit and adjusted EBITDA.

Alignment Healthcare’s quarterly results show robust growth: Health plan membership increased 58% while total revenue increased 52% to $692 million. The company achieved positive adjusted EBITDA of $6 million, marking its second consecutive profitable quarter.

CEO John Kao expressed confidence in the company’s operational efficiency and quality ratings, which will continue to drive expected growth and margin improvements through 2025. Alignment Healthcare projects a minimum growth of 20% in Medicare Advantage memberships and is targeting adjusted EBITDA of over $40 million by 2025. These optimistic forecasts have led TD Cowen to revise its price target upward, reflecting positive expectations for Alignment Healthcare’s future financial performance.

This translation was created using artificial intelligence. For further information, please see our Terms of Use.